100 related articles for article (PubMed ID: 8824895)
1. The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background.
Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M
Mol Cell Endocrinol; 1995 Dec; 115(2):199-206. PubMed ID: 8824895
[TBL] [Abstract][Full Text] [Related]
2. Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model.
Costagliola S; Many MC; Stalmans-Falys M; Tonacchera M; Vassart G; Ludgate M
Endocrinology; 1994 Nov; 135(5):2150-9. PubMed ID: 7956939
[TBL] [Abstract][Full Text] [Related]
3. Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R.
Costagliola S; Alcalde L; Tonacchera M; Ruf J; Vassart G; Ludgate M
Biochem Biophys Res Commun; 1994 Mar; 199(2):1027-34. PubMed ID: 8135775
[TBL] [Abstract][Full Text] [Related]
4. Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB/c and NOD mice.
Costagliola S; Many MC; Stalmans-Falys M; Vassart G; Ludgate M
Endocrinology; 1996 Nov; 137(11):4637-43. PubMed ID: 8895327
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.
Diana T; Krause J; Olivo PD; König J; Kanitz M; Decallonne B; Kahaly GJ
Clin Exp Immunol; 2017 Sep; 189(3):304-309. PubMed ID: 28439882
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the extracellular domain of the thyrotrophin receptor in bacteria; production of thyrotrophin-binding inhibiting immunoglobulins.
Costagliola S; Alcalde L; Ruf J; Vassart G; Ludgate M
J Mol Endocrinol; 1994 Aug; 13(1):11-21. PubMed ID: 7999252
[TBL] [Abstract][Full Text] [Related]
7. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
Baker G; Mazziotti G; von Ruhland C; Ludgate M
Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
[TBL] [Abstract][Full Text] [Related]
8. Development of an animal model of autoimmune thyroid eye disease.
Many MC; Costagliola S; Detrait M; Denef F; Vassart G; Ludgate MC
J Immunol; 1999 Apr; 162(8):4966-74. PubMed ID: 10202044
[TBL] [Abstract][Full Text] [Related]
9. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
10. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
[TBL] [Abstract][Full Text] [Related]
11. Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors.
Grasso YZ; Kim MR; Faiman C; Kohn LD; Tahara K; Gupta MK
Thyroid; 1999 Jun; 9(6):531-7. PubMed ID: 10411114
[TBL] [Abstract][Full Text] [Related]
12. Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor.
Costagliola S; Rodien P; Many MC; Ludgate M; Vassart G
J Immunol; 1998 Feb; 160(3):1458-65. PubMed ID: 9570567
[TBL] [Abstract][Full Text] [Related]
13. The thyrotropin receptor in thyroid eye disease.
Ludgate M; Crisp M; Lane C; Costagliola S; Vassart G; Weetman A; Daunerie C; Many MC
Thyroid; 1998 May; 8(5):411-3. PubMed ID: 9623732
[TBL] [Abstract][Full Text] [Related]
14. Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies.
Diana T; Wüster C; Kanitz M; Kahaly GJ
J Endocrinol Invest; 2016 Oct; 39(10):1159-65. PubMed ID: 27197966
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice.
McLachlan SM; Braley-Mullen H; Chen CR; Aliesky H; Pichurin PN; Rapoport B
Endocrinology; 2005 Jan; 146(1):294-300. PubMed ID: 15459116
[TBL] [Abstract][Full Text] [Related]
16. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
[TBL] [Abstract][Full Text] [Related]
17. Enhanced response to mouse thyroid-stimulating hormone (TSH) receptor immunization in TSH receptor-knockout mice.
Nakahara M; Mitsutake N; Sakamoto H; Chen CR; Rapoport B; McLachlan SM; Nagayama Y
Endocrinology; 2010 Aug; 151(8):4047-54. PubMed ID: 20555026
[TBL] [Abstract][Full Text] [Related]
18. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
19. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
[TBL] [Abstract][Full Text] [Related]
20. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
